Journal
Science Translational Medicine
Volume 8, Issue 362, Pages -Publisher
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/scitranslmed.aaf8732
Keywords
-
Categories
Funding
- German Research Foundation (DFG) [LO817/5-1, SFB 1009 TP-B07, SFB 1009 TP-Z02, SFB-TR128 TP-A10, TP-B06, INST2105/27-1]
- Interdisciplinary Center for Clinical Research (IZKF) [Lo2/004/16]
Ask authors/readers for more resources
In inflammation-associated progressive neuroinflammatory disorders, such as multiple sclerosis (MS), inflammatory infiltrates containing T helper 1 (T(H)1) and T(H)17 cells cause demyelination and neuronal degeneration. Regulatory T cells (T-reg) control the activation and infiltration of autoreactive T cells into the central nervous system (CNS). In MS and experimental autoimmune encephalomyelitis (EAE) in mice, T-reg function is impaired. We show that a recently approved drug, Nle(4)-D-Phe(7)-alpha-melanocyte-stimulating hormone (NDP-MSH), induced functional T-reg, resulting in amelioration of EAE progression in mice. NDP-MSH also prevented immune cell infiltration into the CNS by restoring the integrity of the blood-brain barrier. NDP-MSH exerted long-lasting neuroprotective effects in mice with EAE and prevented excitotoxic death and reestablished action potential firing in mouse and human neurons in vitro. Neuro-protection by NDP-MSH was mediated via signaling through the melanocortin-1 and orphan nuclear 4 receptors in mouse and human neurons. NDP-MSH may be of benefit in treating neuroinflammatory diseases such as relapsing-remitting MS and related disorders.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available